{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:38Z","timestamp":1786990418688,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30851"],"award-info":[{"award-number":["2023JJ30851"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071006"],"award-info":[{"award-number":["82071006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371104"],"award-info":[{"award-number":["82371104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.147867","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T06:20:40Z","timestamp":1758694840000},"page":"147867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Bispecific aptamers target thyrotropin receptor (TSHR) and insulin growth factor-1 receptor (IGF-1R) for the improvement of orbital fibroblasts activation in the treatment of thyroid-associated ophthalmopathy"],"prefix":"10.1016","volume":"330","author":[{"given":"Bingyu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jc.2003-031427","article-title":"Evidence for enhanced adipogenesis in the orbits of patients with Graves\u2019 ophthalmopathy","volume":"89","author":"Kumar","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/jc.2011-1299","article-title":"Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves\u2019 orbitopathy","volume":"97","author":"Zhang","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40662-014-0009-8","article-title":"An overview of thyroid eye disease","volume":"1","author":"McAlinden","year":"2014","journal-title":"Eye Vis (Lond)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(16)30046-8","article-title":"Advances in treatment of active, moderate-to-severe Graves\u2019 ophthalmopathy","volume":"5","author":"Wiersinga","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147867_bb0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/ICU.0000000000000529","article-title":"Thyroid eye disease: what is new to know?","volume":"29","author":"Li","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147867_bb0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/joim.13524","article-title":"Current concepts regarding Graves\u2019 orbitopathy","volume":"292","author":"Bartalena","year":"2022","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","article-title":"2021 update on thyroid-associated ophthalmopathy","volume":"45","author":"Neag","year":"2022","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","article-title":"Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves\u2019 ophthalmopathy","volume":"142","author":"Dik","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147867_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor","volume":"26","author":"Iyer","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147867_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2017.1288215","article-title":"TSHR as a therapeutic target in Graves\u2019 disease","volume":"21","author":"Smith","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147867_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40618-020-01380-9","article-title":"Thyrotropin receptor antibodies and Graves\u2019 orbitopathy","volume":"44","author":"Diana","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147867_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/a-0723-9023","article-title":"Thyrotropin receptor blocking antibodies","volume":"50","author":"Diana","year":"2018","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0070","doi-asserted-by":"crossref","first-page":"1062045","DOI":"10.3389\/fimmu.2023.1062045","article-title":"A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves\u2019 orbitopathy","volume":"14","author":"Cui","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147867_bb0075","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"Krieger","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147867_bb0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1089\/thy.2022.0173","article-title":"A multicenter, single-blind, case-control, immunohistochemical study of orbital tissue in thyroid eye disease","volume":"32","author":"Hai","year":"2022","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147867_bb0090","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1167\/iovs.08-2328","article-title":"Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1","volume":"50","author":"Hwang","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147867_bb0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147867_bb0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147867_bb0105","doi-asserted-by":"crossref","first-page":"E1635","DOI":"10.1210\/jc.2014-1580","article-title":"Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes","volume":"99","author":"Chen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.04.007","article-title":"Aptamer chemistry","volume":"134","author":"Rothlisberger","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","article-title":"Aptamers as therapeutics","volume":"57","author":"Nimjee","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"35","key":"10.1016\/j.ijbiomac.2025.147867_bb0130","article-title":"Molecular aptamer beacons and their applications in sensing, imaging, and diagnostics","volume":"15","author":"Moutsiopoulou","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102666","article-title":"A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine \/collagen content in a long-term Graves\u2019 disease mouse model","volume":"122","author":"Diana","year":"2021","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147867_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4158\/EP-2019-0363","article-title":"Tsh receptor antibodies: relevance & utility","volume":"26","author":"Kahaly","year":"2020","journal-title":"Endocr. Pract."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147867_bb0145","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1210\/clinem\/dgz292","article-title":"Prospective trial of functional thyrotropin receptor antibodies in graves disease","volume":"105","author":"Kahaly","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147867_bb0150","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/jc.2018-02705","article-title":"High titers of thyrotropin receptor antibodies are associated with orbitopathy in patients with graves disease","volume":"104","author":"Kahaly","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4S Suppl 1","key":"10.1016\/j.ijbiomac.2025.147867_bb0155","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","article-title":"Thyroid stimulating hormone receptor antibodies in thyroid eye disease-methodology and clinical applications","volume":"34","author":"Diana","year":"2018","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0160","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.2147\/IJN.S446656","article-title":"A TSHR-targeting aptamer in monocytes correlating with clinical activity in TAO","volume":"19","author":"Cao","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147867_bb0165","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.7150\/thno.17826","article-title":"Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth","volume":"7","author":"Zheng","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147867_bb0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12967-023-04217-0","article-title":"RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147867_bb0175","first-page":"2620","article-title":"Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts","volume":"80","author":"Smith","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147867_bb0180","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1167\/iovs.08-2443","article-title":"Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves\u2019 ophthalmopathy","volume":"50","author":"van Steensel","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"62","key":"10.1016\/j.ijbiomac.2025.147867_bb0185","doi-asserted-by":"crossref","first-page":"105126","DOI":"10.18632\/oncotarget.21757","article-title":"Low density lipoprotein - rosiglitazone - chitosan-calcium alginate\/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147867_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.21037\/gs-21-908","article-title":"Lysyl oxidase promotes anaplastic thyroid carcinoma cell proliferation and metastasis mediated via BMP1","volume":"11","author":"Liu","year":"2022","journal-title":"Gland Surg."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147867_bb0195","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim","volume":"111","author":"Chen","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147867_bb0200","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40618-022-01902-7","article-title":"The role and molecular mechanism of gut microbiota in Graves\u2019 orbitopathy","volume":"46","author":"Li","year":"2023","journal-title":"J. Endocrinol. Invest."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147867_bb0205","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/nprot.2016.081","article-title":"High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue","volume":"11","author":"Ly","year":"2016","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147867_bb0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1586\/17446651.3.4.473","article-title":"Thyroid-stimulating hormone\/cAMP-mediated proliferation in thyrocytes","volume":"3","author":"Garc\u00eda-Jim\u00e9nez","year":"2008","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147867_bb0215","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/jcp.24952","article-title":"TSH\/TSHR signaling suppresses fatty acid synthase (FASN) expression in adipocytes","volume":"230","author":"Chen","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147867_bb0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/ed1000125","article-title":"Measuring binding affinity of protein\u2212ligand interaction using spectrophotometry: binding of neutral red to riboflavin-binding protein","volume":"87","author":"Chenprakhon","year":"2010","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/srep39774","article-title":"Determination of equilibrium dissociation constants for recombinant antibodies by high-throughput affinity electrophoresis","volume":"6","author":"Pan","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147867_bb0230","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147867_bb0235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/stem.1648","article-title":"Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing","volume":"32","author":"Suga","year":"2014","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147867_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043359","article-title":"Evaluation of epithelial-mesenchymal transition markers in autoimmune thyroid diseases","volume":"24","author":"Sacristan-Gomez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147867_bb0245","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","article-title":"Alpha-smooth muscle actin expression upregulates fibroblast contractile activity","volume":"12","author":"Hinz","year":"2001","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147867_bb0250","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147867_bb0255","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2249.2005.02824.x","article-title":"Insights into the role of fibroblasts in human autoimmune diseases","volume":"141","author":"Smith","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-398313-8.00006-3","article-title":"Adiponectin and PPARgamma: cooperative and interdependent actions of two key regulators of metabolism","volume":"90","author":"Astapova","year":"2012","journal-title":"Vitam. Horm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147867_bb0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cmet.2006.07.001","article-title":"Transcriptional control of adipocyte formation","volume":"4","author":"Farmer","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147867_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010124","article-title":"Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules","volume":"17","author":"Moseti","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.147867_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-007-9661-9","article-title":"Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells","volume":"310","author":"Yu","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147867_bb0280","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/fft2.251","article-title":"6-Gingerol induces browning of white adipose tissue to improve obesity through PI3K\/AKT-RPS6-mediated thermogenesis pathway","volume":"4","author":"Alhamoud","year":"2023","journal-title":"Food Front."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147867_bb0285","doi-asserted-by":"crossref","first-page":"E1183","DOI":"10.1210\/jc.2013-4182","article-title":"Possible targets for nonimmunosuppressive therapy of Graves\u2019 orbitopathy","volume":"99","author":"Zhang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147867_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024663","article-title":"Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms","volume":"6","author":"Conte","year":"2011","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147867_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311093","article-title":"Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K\/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy","volume":"19","author":"Lee","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.147867_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","article-title":"Molecular biomarkers of Graves\u2019 ophthalmopathy","volume":"106","author":"Longo","year":"2019","journal-title":"Exp. Mol. Pathol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025084247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025084247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:58:56Z","timestamp":1762477136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025084247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"alternative-id":["S0141813025084247"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147867","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bispecific aptamers target thyrotropin receptor (TSHR) and insulin growth factor-1 receptor (IGF-1R) for the improvement of orbital fibroblasts activation in the treatment of thyroid-associated ophthalmopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"147867"}}